Citations 2
Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Riba, Michelle B., Donovan, Kristine A. , Andersen, Barbara L. , Braun, IIana, Breitbart, William , Brewer, Benjamin W. , Buchmann, Luke, Clark, Matthew M. , Collins, Molly, Corbett, Cheyenne , Fleishman, Stewart B., Garcia, Sofia F. , Greenberg, Donna, Handzo, Rev. George F., Hoofring, Laura, Huang, Chao‐Hui , Martin, Sara , McGuffey, Lisa, Mitchell, William M. , Morrison, Laura , Pailler, Megan E. , Parnes, Francine, Pazar, Janice P., Ralston, Laurel, Salman, Jaroslava, Shannon-Dudley, Moreen, Valentine, Alan , McMillian, Nicole R., Darlow, Susan, Garcia, Sofia F , Handzo, Rev. George F., Lally, Robin Mary , Mitchell, William, Palesh, Oxana Gronskaya
Journal of the National Comprehensive Cancer Network | October 7, 2019 | Volume: 17 | Issue: 10 | Pages: 1229-1249
Distress is defined in the NCCN Guidelines for Distress Management as a multifactorial, unpleasant experience of a psychologic (ie, cognitive, behavioral, emotional), social, spiritual, and/or physical nature that may interfere with the ability to cope effectively with cancer, its physical symptoms, and its treatment. Early evaluation and screening for distress leads to early and timely management of psychologic distress, which in turn improves medical management. The panel for the Distress Management Guidelines recently added a new principles section including guidance on implementation of standards of psychosocial care for patients with cancer.
Conducting Cancer Control and Survivorship Research via Cooperative Groups: A Report from the American Society of Preventive Oncology
Demark‐Wahnefried, Wendy , Mustian, Karen M. , Minasian, Lori M. , Rowland, Julia, Sprod, Lisa K., Janelsins, Michelle C. , Peppone, Luke J. , Sloan, Jeff A. , Engquist, Karen Basen, Palesh, Oxana Gronskaya , Jones, Lee W. , Buist, Diana S.M. , Paskett, Electra D. , Demark-Wahnefried, Wendy
Cancer Epidemiology, Biomarkers & Prevention | May 5, 2011 | Volume: 20 | Issue: 5 | Pages: 1050-1055
Abstract As the number of cancer survivors expands, the need for cancer control and survivorship research becomes increasingly important. The National Cancer Institute (NCI) Cooperative Groups may offer a viable platform to perform such research. Observational, preventive, and behavioral research can often be performed within the cooperative group setting, especially if resources needed for evaluation are fairly simple, if protocols are easily implemented within the typical clinical setting, and if interventions are well standardized. Some protocols are better suited to cooperative groups than are others, and there are advantages and disadvantages to conducting survivorship research within the cooperative group setting. Behavioral researchers currently involved in cooperative groups, as well as program staff within the NCI, can serve as sources of information for those wishing to pursue symptom management and survivorship studies within the clinical trial setting. The structure of the cooperative groups is currently changing, but going forward, survivorship is bound to be a topic of interest and one that perhaps may be more easily addressed using the proposed more centralized structure. Cancer Epidemiol Biomarkers Prev; 20(5); 1050–5. ©2011 AACR.